用于医疗或药物用途，例如注射，输注或针筒柱塞止动器弹性体组件必须是惰性的，它们接触的解决方案。 他们还必须有一个预定的滑动和静摩擦性能。 为了确保这一点，已知的是，以提供与相应的层中的弹性体成分，弹性体组分单独涂覆有现有技术。 作为弹性体组分在具有多个被单独冲压出一体成形凸出弹性体组分的扩展区域垫的形式典型地由，本发明提供涂覆垫作为一个整体与弹性体组分通常PECVD工艺和仅在其后后 切出从垫的各个弹性体组分。

Elastomeric components for medical or pharmaceutical purposes such as injection, infusion or syringe plunger stopper must be inert to the solutions with which they come into contact. They shall have a predetermined sliding and stiction assets. To ensure this, it is known to provide the elastomer component with a corresponding layer, wherein in the prior art, the elastomeric component can be coated individually. As the elastomeric components are typically mixed with a plurality of integrally molded projecting elastomeric components, which are punched out individually prepared in the form of extended-area mats, the invention proposes to coat the mat as a whole with the elastomer components typically after the PECVD process and only thereafter punch out the individual elastomer components from the mat.